HARVEY J. DWORKEN, M.D.
This content is PDF only. Please click on the PDF icon to access.
Physicians who treat patients with Crohn disease should take heart. Recent studies suggesting indications for and efficacy of various therapies for the disease are remarkable, considering that knowledge of its cause has not as yet moved very far beyond the killer lymphocyte stage (1) and shows no signs of early progress therefrom.
Therapy in Crohn disease should be tailored to the stage of the disorder. Although detailed staging techniques have been developed (2, 3), they are almost too clumsy for use in daily practice where a simpler classification is preferable. Thus, patients can usually be assigned to one of three
DWORKEN HJ. Crohn Disease: A Hopeful Note. Ann Intern Med. 1981;95:777–778. doi: https://doi.org/10.7326/0003-4819-95-6-777
Download citation file:
Published: Ann Intern Med. 1981;95(6):777-778.
Gastroenterology/Hepatology, Inflammatory Bowel Disease.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use